CLBIO — Corline Biomedical AB Share News
0.000.00%
- SEK371.09m
- SEK338.10m
- SEK7.65m
Brief: Corline Biomedical carries out new share issue of about SEK 15 mln
Brief: Corline Biomedical Q2 operating loss widens to SEK 2.0 mln
Brief: Corline Biomedical signs LOI with University of Alberta
Brief: Corline Biomedical signs LOI with Oxford University for clinical study
Brief: Corline Biomedical: heparin substance granted orphan-drug designation by FDA
Brief: Corline Biomedical: NPITG requires additional preclinical data on Cytoparin
Brief: Corline Biomedical Q4 pre-tax loss narrows to SEK 1.5 million
Brief: Corline: Cytoparin-study postponed
Brief: Corline Biomedical receives grant from EU-commission
Brief: Corline Biomedical Q3 pre-tax loss widens to SEK 1.3 million
Brief: Corline Biomedical Q3 pre-tax loss widens to SEK 1.3 mln
Brief: Corline Biomedical signs contract for GMP production and toxicology study of Renaparin
Brief: Corline Biomedical Q2 operating loss down at SEK 0.6 mln
Brief: Corline Biomedical: Renaparin receives SEK 1 mln grant from Vinnova
Brief: Corline Biomedical Q1 pre-tax loss widens to SEK 1.8 million
Brief: Corline Biomedical: Animal study shows Renaparin improves kidney function after transplantation
Brief: Corline Biomedical registers Renaparin trademark in EU
Brief: Corline Biomedical rights issue oversubscribed 125.4 pct
Brief: Corline Biomedical Q4 operating loss widens to SEK 2.2 mln